Colitis or inflammatory bowel disease. You may have heard of inflammatory bowel disease (IBD) but don’t really understand the difference between IBD and IBS (irritable bowel syndrome). This month we ...

Ulcerative colitis is a debilitating illness with genetic, nutritional or lifestyle causes. It can often be controlled by ...

A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most ...

The most common forms of inflammatory bowel disease (IBD) are ulcerative colitis and Crohn's disease. But there is a third diagnosis—indeterminate colitis. The term indeterminate colitis is used when ...

Ulcerative colitis is a form of inflammatory bowel disease (IBD), a chronic disease for which there is currently no known cure. The primary sign of the condition is inflammation of the colon and ...

US affiliate and partner Sanofi (SNY) said Tuesday that a phase 2b study of Teva's investigational duvakitug drug to treat ulcerative colitis and Crohn's disease met its primary endpoints. Ulcerative ...

Discover how β-ionone offers relief from ulcerative colitis by enhancing gut health, reducing inflammation, and restoring ...

This week marks the annual Crohn’s and Colitis Awareness Week, which recognizes two conditions that are related to ...

Shares of Teva Pharmaceutical Industries surged more than 23% on Tuesday afternoon, reaching levels not seen since December ...

Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today announced that the RELIEVE UCCD phase 2b study met its primary endpoints in patients with ulcerative ...

At Christmas people with Crohn’s disease and ­colitis can often be left at risk of a digestive flare-up as they are tempted ...